Trius Therapeutics Inc 4
4 · Trius Therapeutics Inc · Filed Jun 3, 2013
Insider Transaction Report
Form 4
Onaitis Matthew
General Counsel
Transactions
- Award
Stock Option (right to buy)
2013-05-31+100,000→ 100,000 totalExercise: $7.67Exp: 2023-05-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on May 31, 2014, and the remainder shall vest in 36 successive equal monthly installments thereafter until fully vested on May 31, 2017.